Skip to content

Therapeutic Effects and Altered Brain Connectivity Following Fu's Subcutaneous Needling Treatment in Post-Stroke Hemiplegic Patients

Therapeutic Effects and Altered Brain Connectivity Following Fu's Subcutaneous Needling Treatment in Post-Stroke Hemiplegic Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001698
Enrollment
Unknown
Registered
2025-09-09
Start date
2025-09-10
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Stroke Hemiplegic

Interventions

FSN group:FSN+Conventional rehabilitation therapy
sham FSN group:sham FSN+Conventional rehabilitation therapy
control group:Conventional rehabilitation therapy

Sponsors

Jiangsu Province Official Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Confirmed stroke diagnosis per the Fourth National Cerebrovascular Disease Conference criteria, with ischemic/hemorrhagic etiology verified by CT/MRI; 2) Independent ambulation capacity >60 meters (without assistive devices, no gait speed restriction) with documented pathological gait patterns (e.g., knee hyperextension, foot drop, inverted foot); 3) Age 18-65 years.

Exclusion criteria

Exclusion criteria: 1) Organic lesions of extremities; 2) Botulinum toxin injections or oral spasticity medications (e.g., baclofen, botulinum toxin) within 3 months prior; 3) Severe cardiopulmonary diseases; 4) Significant hepatic/renal dysfunction (Child-Pugh grade C or eGFR <30 mL/min/1.73m²); 5) Intracranial metal implants contraindicating MRI; 6) Severe cognitive impairment (MMSE score <10); 7) Pregnancy.

Design outcomes

Primary

MeasureTime frame
motor ability;walking ability;

Secondary

MeasureTime frame
muscle tone level;muscle strength level;balance ability;activity of daily living;brain connectivity;

Countries

China

Contacts

Public ContactQingyu Meng

Jiangsu Province Official Hospital

qingyum2@163.com15365008000

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026